Lupin Pharmaceuticals is the U.S. wholly-owned subsidiary of Lupin Limited, a top pharmaceutical company in India. Since its establishment in 2003, Lupin has been dedicated to delivering high-quality, branded and generic medications trusted by healthcare professionals and patients across geographies. With its sales and marketing headquarters located in Baltimore, MD, the company aims to treat diseases, heal, and enrich human life, as reflected in its slogan: "There is only one reason why we exist — to treat diseases, to heal and enrich human life." Despite lacking specific information about its industries, headquarters, or recent investments and investors, Lupin Pharmaceuticals presents a solid foundation as a subsidiary of a well-established pharmaceutical giant, Lupin Limited.
There is no investment information
No recent news or press coverage available for Lupin Pharmaceuticals.